Cargando…

Identification of genes modified by N6-methyladenosine in patients with colorectal cancer recurrence

Background: Recent studies demonstrate that N6-methyladenosine (m(6)A) methylation plays a crucial role in colorectal cancer (CRC). Therefore, we conducted a comprehensive analysis to assess the m(6)A modification patterns and identify m(6)A-modified genes in patients with CRC recurrence. Methods: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Qianru, Huang, Xingxing, Yu, Shuxian, Shou, Lan, Zhang, Ruonan, Xie, Han, Liang, Zimao, Sun, Xueni, Feng, Jiao, Duan, Ting, Zhang, Mingming, Xiang, Yu, Sui, Xinbing, Jin, Weiwei, Yu, Lili, Wu, Qibiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618605/
https://www.ncbi.nlm.nih.gov/pubmed/36324506
http://dx.doi.org/10.3389/fgene.2022.1043297
_version_ 1784821086777507840
author Zhu, Qianru
Huang, Xingxing
Yu, Shuxian
Shou, Lan
Zhang, Ruonan
Xie, Han
Liang, Zimao
Sun, Xueni
Feng, Jiao
Duan, Ting
Zhang, Mingming
Xiang, Yu
Sui, Xinbing
Jin, Weiwei
Yu, Lili
Wu, Qibiao
author_facet Zhu, Qianru
Huang, Xingxing
Yu, Shuxian
Shou, Lan
Zhang, Ruonan
Xie, Han
Liang, Zimao
Sun, Xueni
Feng, Jiao
Duan, Ting
Zhang, Mingming
Xiang, Yu
Sui, Xinbing
Jin, Weiwei
Yu, Lili
Wu, Qibiao
author_sort Zhu, Qianru
collection PubMed
description Background: Recent studies demonstrate that N6-methyladenosine (m(6)A) methylation plays a crucial role in colorectal cancer (CRC). Therefore, we conducted a comprehensive analysis to assess the m(6)A modification patterns and identify m(6)A-modified genes in patients with CRC recurrence. Methods: The m(6)A modification patterns were comprehensively evaluated by the NMF algorithm based on the levels of 27 m(6)A regulators, and tumor microenvironment (TME) cell-infiltrating characteristics of these modification patterns were systematically assessed by ssGSEA and CIBERSORT algorithms. The principal component analysis algorithm based on the m(6)A scoring scheme was used to explore the m(6)A modification patterns of individual tumors with immune responses. The weighted correlation network analysis and univariable and multivariable Cox regression analyses were applied to identify m(6)A-modified gene signatures. The single-cell expression dataset of CRC samples was used to explore the tumor microenvironment affected by these signatures. Results: Three distinct m(6)A modification patterns with significant recurrence-free survival (RFS) were identified in 804 CRC patients. The TME characterization revealed that the m(6)A modification pattern with longer RFS exhibited robust immune responses. CRC patients were divided into high- and low-score subgroups according to the m(6)A score individually, which was obtained from the m(6)A-related signature genes. The patients with low m(6)A scores had both longer RFS and overall survival (OS) with altered immune cell infiltration. Notably, m(6)A-modified genes showed significant differences related to the prognosis of CRC patients in the meta-GEO cohort and TCGA cohort. Single-cell expression indicated that ALVRL1 was centrally distributed in endothelial tip cells and stromal cells. Conclusion: The m(6)A modification plays an indispensable role in the formation of TME diversity and complexity. Importantly, the signatures (TOP2A, LRRC58, HAUS6, SMC4, ACVRL1, and KPNB1) were identified as m(6)A-modified genes associated with CRC recurrence, thereby serving as a promising predictive biomarker or therapeutic target for patients with CRC recurrence.
format Online
Article
Text
id pubmed-9618605
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96186052022-11-01 Identification of genes modified by N6-methyladenosine in patients with colorectal cancer recurrence Zhu, Qianru Huang, Xingxing Yu, Shuxian Shou, Lan Zhang, Ruonan Xie, Han Liang, Zimao Sun, Xueni Feng, Jiao Duan, Ting Zhang, Mingming Xiang, Yu Sui, Xinbing Jin, Weiwei Yu, Lili Wu, Qibiao Front Genet Genetics Background: Recent studies demonstrate that N6-methyladenosine (m(6)A) methylation plays a crucial role in colorectal cancer (CRC). Therefore, we conducted a comprehensive analysis to assess the m(6)A modification patterns and identify m(6)A-modified genes in patients with CRC recurrence. Methods: The m(6)A modification patterns were comprehensively evaluated by the NMF algorithm based on the levels of 27 m(6)A regulators, and tumor microenvironment (TME) cell-infiltrating characteristics of these modification patterns were systematically assessed by ssGSEA and CIBERSORT algorithms. The principal component analysis algorithm based on the m(6)A scoring scheme was used to explore the m(6)A modification patterns of individual tumors with immune responses. The weighted correlation network analysis and univariable and multivariable Cox regression analyses were applied to identify m(6)A-modified gene signatures. The single-cell expression dataset of CRC samples was used to explore the tumor microenvironment affected by these signatures. Results: Three distinct m(6)A modification patterns with significant recurrence-free survival (RFS) were identified in 804 CRC patients. The TME characterization revealed that the m(6)A modification pattern with longer RFS exhibited robust immune responses. CRC patients were divided into high- and low-score subgroups according to the m(6)A score individually, which was obtained from the m(6)A-related signature genes. The patients with low m(6)A scores had both longer RFS and overall survival (OS) with altered immune cell infiltration. Notably, m(6)A-modified genes showed significant differences related to the prognosis of CRC patients in the meta-GEO cohort and TCGA cohort. Single-cell expression indicated that ALVRL1 was centrally distributed in endothelial tip cells and stromal cells. Conclusion: The m(6)A modification plays an indispensable role in the formation of TME diversity and complexity. Importantly, the signatures (TOP2A, LRRC58, HAUS6, SMC4, ACVRL1, and KPNB1) were identified as m(6)A-modified genes associated with CRC recurrence, thereby serving as a promising predictive biomarker or therapeutic target for patients with CRC recurrence. Frontiers Media S.A. 2022-10-17 /pmc/articles/PMC9618605/ /pubmed/36324506 http://dx.doi.org/10.3389/fgene.2022.1043297 Text en Copyright © 2022 Zhu, Huang, Yu, Shou, Zhang, Xie, Liang, Sun, Feng, Duan, Zhang, Xiang, Sui, Jin, Yu and Wu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Zhu, Qianru
Huang, Xingxing
Yu, Shuxian
Shou, Lan
Zhang, Ruonan
Xie, Han
Liang, Zimao
Sun, Xueni
Feng, Jiao
Duan, Ting
Zhang, Mingming
Xiang, Yu
Sui, Xinbing
Jin, Weiwei
Yu, Lili
Wu, Qibiao
Identification of genes modified by N6-methyladenosine in patients with colorectal cancer recurrence
title Identification of genes modified by N6-methyladenosine in patients with colorectal cancer recurrence
title_full Identification of genes modified by N6-methyladenosine in patients with colorectal cancer recurrence
title_fullStr Identification of genes modified by N6-methyladenosine in patients with colorectal cancer recurrence
title_full_unstemmed Identification of genes modified by N6-methyladenosine in patients with colorectal cancer recurrence
title_short Identification of genes modified by N6-methyladenosine in patients with colorectal cancer recurrence
title_sort identification of genes modified by n6-methyladenosine in patients with colorectal cancer recurrence
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618605/
https://www.ncbi.nlm.nih.gov/pubmed/36324506
http://dx.doi.org/10.3389/fgene.2022.1043297
work_keys_str_mv AT zhuqianru identificationofgenesmodifiedbyn6methyladenosineinpatientswithcolorectalcancerrecurrence
AT huangxingxing identificationofgenesmodifiedbyn6methyladenosineinpatientswithcolorectalcancerrecurrence
AT yushuxian identificationofgenesmodifiedbyn6methyladenosineinpatientswithcolorectalcancerrecurrence
AT shoulan identificationofgenesmodifiedbyn6methyladenosineinpatientswithcolorectalcancerrecurrence
AT zhangruonan identificationofgenesmodifiedbyn6methyladenosineinpatientswithcolorectalcancerrecurrence
AT xiehan identificationofgenesmodifiedbyn6methyladenosineinpatientswithcolorectalcancerrecurrence
AT liangzimao identificationofgenesmodifiedbyn6methyladenosineinpatientswithcolorectalcancerrecurrence
AT sunxueni identificationofgenesmodifiedbyn6methyladenosineinpatientswithcolorectalcancerrecurrence
AT fengjiao identificationofgenesmodifiedbyn6methyladenosineinpatientswithcolorectalcancerrecurrence
AT duanting identificationofgenesmodifiedbyn6methyladenosineinpatientswithcolorectalcancerrecurrence
AT zhangmingming identificationofgenesmodifiedbyn6methyladenosineinpatientswithcolorectalcancerrecurrence
AT xiangyu identificationofgenesmodifiedbyn6methyladenosineinpatientswithcolorectalcancerrecurrence
AT suixinbing identificationofgenesmodifiedbyn6methyladenosineinpatientswithcolorectalcancerrecurrence
AT jinweiwei identificationofgenesmodifiedbyn6methyladenosineinpatientswithcolorectalcancerrecurrence
AT yulili identificationofgenesmodifiedbyn6methyladenosineinpatientswithcolorectalcancerrecurrence
AT wuqibiao identificationofgenesmodifiedbyn6methyladenosineinpatientswithcolorectalcancerrecurrence